Hyunryul Ryu

Title: Innovations of Hyunryul Ryu in Micro-Fluidics

Introduction

Hyunryul Ryu is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of micro-fluidics, particularly in the area of particle isolation and detection techniques. With a total of 2 patents, Ryu's work is paving the way for advancements in medical diagnostics.

Latest Patents

Ryu's latest patents include two groundbreaking inventions. The first is titled "Particle isolation/enrichment using continuous closed-loop micro-fluidics." This invention encompasses a micro-fluidic system with a closed-loop configuration that allows for the continuous inertial separation of particles and cells. By feeding part of the output back to the input, the system maximizes the purity and concentration of the particles or cells. The invention also outlines methods for utilizing this micro-fluidic system effectively.

The second patent is "Liquid biopsy detection of leukemia using closed-loop microfluidics." This invention describes a one-step technique for the simultaneous label-free detection and concentration of blast cells from blood samples. The closed-loop microfluidics system enables the continuous removal of waste and non-target cells, resulting in concentrated samples of high purity. This technique is particularly effective for samples that cannot be purified in a single run, making it invaluable for monitoring minimal residual disease in leukemia patients.

Career Highlights

Hyunryul Ryu is affiliated with the Massachusetts Institute of Technology, where he continues to innovate and contribute to research in micro-fluidics. His work has garnered attention for its potential applications in medical diagnostics and treatment monitoring.

Collaborations

Ryu has collaborated with notable colleagues, including Kyungyong Choi and Jongyoon Han, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Hyunryul Ryu's contributions to micro-fluidics represent a significant advancement in medical technology. His innovative patents are set to improve diagnostic techniques and patient outcomes in the field of leukemia detection.